Microarray Analysis Industry Analysis, Top Leaders and Forecast Report 2030

In 2021, the microarray analysis market was worth around USD 3,846.7 million, and it is projected to advance at a 9.9% CAGR from 2021 to 2030, hitting USD 9,011.1 million in 2030, according to P&S Intelligence.

This growth can be credited to the rising application extent of microarrays, several government steps for proteomic and genomic research, and the increasing occurrence of cancer. Microarray analysis is commonly utilized in medicinal screening, toxicology screening, and biomarker identification to detect mutation in the DNA. Furthermore, microarray analysis can also be utilized for showing several genetic factors at the same time, which is one of its major benefits.

In 2021, worldwide, North America held the largest market share, at approximately 40%. It is projected to experience significant development in the coming few years, credited to the fact that governments in Canada and the U.S. are constantly growing their investment in cancer research.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/microarray-analysis-market/report-sample

During the forecast period, the consumables category will develop at the highest CARG, of above 10%, on the basis of product and service, credited to the increasing number of diagnostic labs and research centers using microarray analysis. Furthermore, the growing research on mRNA and DNA methylation boosts the consumption of consumables for functioning microarray analyses.

In 2021, the DNA microarrays category had the largest industry share, and the same category is projected to experience a CAGR of approximately 10% in the coming few years. This is mainly because DNA microarrays are utilized in clinical diagnostic tests for a count of illnesses.

Moreover, they are also utilized to regulate which drug may be the finest prescribed to a precise patient, as genetic factor controls how the body manages the chemistry of medicines.

In 2021, research and academic institutes had the largest microarray analysis market share and are projected to generate revenue of USD 4.0 billion by 2030. The number of human genome study projects has amplified in recent years. Mainly, microarrays are utilized for the finding of cancer medications. Thus, the growing research and development expenditure in the healthcare industry is projected to boost the growth of the market.  

After North America, Europe is the second-largest market, mainly because of its well-established healthcare sector, progressive R&D infrastructure, and convenience in getting associated products. The use of point-of-care testing for cancer discovery has amplified in recent years in the region, therefore boosting the microarray analysis growth of the market.

Hence, the rising application extent of microarrays, several government steps for proteomic and genomic research, and increasing occurrence of cancer and also the usage of microarray analysis in medicinal screening, toxicology screening and biomarker identification to detect mutation in the DNA are the major factors propelling microarray analysis industry.

About P&S Intelligence

P&S Intelligence is a market research and consulting firm shaping growth strategies for enterprises with a global as well as niche presence. We specialize in both syndicate and custom market research, creating insight-laden reports that allow customers to stay ahead at every curve. Our clients range from multi-billion-dollar behemoths across industries to up and coming MSMEs and startups. Moreover, with our new offering, government and public sector advisory services, we continue to trudge ahead in our quest for revolutionizing the way economies shape themselves in these ever-changing times.